Nasonex Nasal Spray: Effective Relief for Nasal Allergy Symptoms
| Product dosage: 18g | |||
|---|---|---|---|
| Package (num) | Per sprayer | Price | Buy |
| 2 | $31.29 | $62.58 (0%) | 🛒 Add to cart |
| 3 | $30.28 | $93.88 $90.85 (3%) | 🛒 Add to cart |
| 4 | $29.53 | $125.17 $118.10 (6%) | 🛒 Add to cart |
| 5 | $28.87 | $156.46 $144.35 (8%) | 🛒 Add to cart |
| 6 | $28.60 | $187.75 $171.60 (9%) | 🛒 Add to cart |
| 7 | $28.26 | $219.05 $197.85 (10%) | 🛒 Add to cart |
| 8 | $28.14 | $250.34 $225.10 (10%) | 🛒 Add to cart |
| 9 | $28.04 | $281.63 $252.36 (10%) | 🛒 Add to cart |
| 10 | $27.86
Best per sprayer | $312.92 $278.60 (11%) | 🛒 Add to cart |
Synonyms | |||
Nasonex Nasal Spray (mometasone furoate monohydrate) is a prescription corticosteroid spray designed for the management of nasal symptoms associated with seasonal and perennial allergic rhinitis in adults and pediatric patients. It works locally in the nasal passages to reduce inflammation, providing targeted relief from congestion, sneezing, and runny nose. Clinically proven and widely recommended by allergists, Nasonex offers a non-sedating, long-term solution for allergy sufferers seeking to improve respiratory comfort and quality of life.
Features
- Active ingredient: mometasone furoate monohydrate (50 mcg per spray)
- Delivery system: metered-dose, manual pump spray bottle
- Prescription strength formulation
- Alcohol-free and non-habit forming
- Suitable for patients aged 2 years and older
- Once-daily dosing regimen after initial stabilization
Benefits
- Reduces nasal inflammation at the source, alleviating congestion, sneezing, and rhinorrhea
- Provides 24-hour symptom control with once-daily use, supporting treatment adherence
- Minimizes systemic absorption due to localized action, reducing risk of steroid-related side effects
- Non-drowsy formula allows for unimpaired daytime activity and focus
- Prevents recurrence of nasal polyps following surgical removal
- Improves overall quality of life by enabling normal breathing and sleep
Common use
Nasonex is primarily indicated for the treatment of seasonal and perennial allergic rhinitis symptoms. It is also approved for the prophylaxis of seasonal allergic rhinitis symptoms when initiated 2–4 weeks prior to the anticipated start of the pollen season. Additionally, it is used for the treatment of nasal polyps in adults, both as a monotherapy and as an adjunct to surgery.
Dosage and direction
For allergic rhinitis in adults and adolescents 12 years and older: 2 sprays in each nostril once daily (total 200 mcg/day). For children 2–11 years: 1 spray in each nostril once daily (total 100 mcg/day). For nasal polyps in adults: 2 sprays in each nostril twice daily (total 400 mcg/day). Shake well before use. Prime the pump before first use or if not used for 14 days or more. Blow nose gently before administration. Tilt head slightly forward and insert tip into nostril, pointing away from the nasal septum. Breathe in gently while spraying.
Precautions
Avoid use in patients with recent nasal septum ulcers, nasal surgery, or nasal trauma until fully healed. Use with caution in patients with tuberculosis, untreated fungal, bacterial, or viral infections, or ocular herpes simplex. Monitor for signs of adrenal suppression if used long-term or at high doses. Nasal corticosteroids may slow growth in children; regularly monitor pediatric patients. Avoid exposure to chickenpox or measles if not previously immunized.
Contraindications
Hypersensitivity to mometasone furoate or any component of the formulation. Not for use in the presence of untreated localized infection involving the nasal mucosa.
Possible side effects
Common side effects (≥1%) include headache, nasal irritation, pharyngitis, epistaxis, and cough. Less frequently reported effects include nasal burning, ulceration, and perforation of the nasal septum. Systemic effects such as adrenal suppression, glaucoma, cataracts, and growth suppression may occur with prolonged use or high doses. Immediate hypersensitivity reactions, including urticaria, angioedema, and bronchospasm, have been reported rarely.
Drug interaction
No formal drug interaction studies have been conducted with Nasonex. However, caution is advised with concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole), which may increase systemic exposure to mometasone. Use with other nasal corticosteroids may increase the risk of hypothalamic-pituitary-adrenal (HPA) axis suppression.
Missed dose
If a dose is missed, administer as soon as remembered. If it is near the time of the next dose, skip the missed dose and resume the regular dosing schedule. Do not double the dose to catch up.
Overdose
Acute overdose is unlikely due to low systemic bioavailability. If excessive doses are administered chronically, systemic glucocorticoid effects such as hypercorticism and adrenal suppression may occur. Treatment should be symptomatic and supportive. There is no specific antidote.
Storage
Store at room temperature (15–30°C or 59–86°F). Do not freeze. Keep the bottle tightly closed and stored with the dust cap in place. Discard after 120 actuations following initial priming, as the amount of medication per spray may decrease substantially thereafter.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult a healthcare provider for diagnosis and personalized treatment recommendations. Do not initiate or discontinue medication without medical supervision.
Reviews
“After years of struggling with seasonal allergies, Nasonex has been a game-changer. My congestion and sneezing are under control without making me drowsy.” – Maria K., verified patient
“As an allergist, I frequently prescribe Nasonex for its efficacy and safety profile. Patients appreciate the once-daily dosing and noticeable improvement in nasal symptoms.” – Dr. Evan R., MD